-
Stocks News
Trump slams economic conditions in Wisconsin city for lack of job promises By Reuters
Author: Gram Slattery RACINE, Wis. (Reuters) – Republican presidential candidate Donald Trump sought to present himself as the best candidate…
Read More » -
Bitcoin
#FreeSamourai
Samourai Wallet From the start, Samourai Wallet have been transparent about their services. They provided their code fully open sourced…
Read More » -
Blockchain
CryptoHub Announces Hit Zone Pre-Seed Incubation
Cryptohub announced incubation. hit zone Launchpad presents this exciting 1VS1 shuffleboard game that promises to bring a new twist to…
Read More » -
Crypto Mining
Arkham is offering a $150,000 bounty to find out who is behind the Trump-themed DJT tokens.
Token Project • June 18, 2024 6:23 PM EDT Posted 1 minute ago In ~ Proposed by Arkham Intelligence. $150,000…
Read More » -
Ethereum
The spot Ethereum ETF is expected to begin trading on July 2. Could this push ETH to $10,000?
The debate over when the Spot Ethereum ETF will begin trading continues to heat up. This time, Bloomberg analyst Eric…
Read More » -
Stocks News
AMD: Upgrade Ahead of Accelerating Growth (NASDAQ:AMD)
JHVEPhotography investment thesis Advanced Micro Devices, Inc. (NASDAQ:AMD) remains one of the most attractive alternative investments in AI chips besides…
Read More » -
Bitcoin
Once again, Trezor takes charge: What is multi-share backup and why you need to know about it. | Billy Campbell | June 2024
Does the thought of protecting your cryptocurrency make you feel burdened? Do not worry. you are not alone! Whether you’re…
Read More » -
Blockchain
What is TensorFlow in Neural Networks?
Machine learning has been one of the most complex areas of technology. Interestingly, tools like Google’s TensorFlow make it easier…
Read More » -
Ethereum
Hedge Funds Betting on SEC-Approved Spot Ethereum ETF – VanEck
Matthew Sigel, head of digital asset research at VanEck, believes financial institutions are preparing for the imminent launch of a…
Read More » -
Stocks News
AbbVie announces that the FDA has approved Skyrizi for ulcerative colitis.
AbbVie said the much-hyped drug is now approved for four diseases spanning so-called “immune-mediated” inflammatory diseases.
Read More »
